<table>
<tr>
                                            <td vAlign="top" align="left" width="1375" height="64">
                                              <p class="MsoNormal" style="line-height: normal">
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												&nbsp;</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
												&nbsp;Biosafety Act, 
												2011&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Act 
												831 </span></b></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												ARRANGEMENT OF SECTIONS </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Section</span></i></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Scope, objectives and 
												establishment </span></i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												1.<span style="font-family: Arial,sans-serif">Scope 
												of the Act </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												2.<span style="font-family: Arial,sans-serif">Objectives 
												of the Act </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												3.<span style="font-family: Arial,sans-serif">Establishment 
												of the National Biosafety 
												Authority </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												4.<span style="font-family: Arial,sans-serif">Functions 
												of the Authority </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												5.<span style="font-family: Arial,sans-serif">The 
												governing body </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Administration </span></i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												6.<span style="font-family: Arial,sans-serif">Conduct 
												of business and affairs of the 
												Board </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												7.<span style="font-family: Arial,sans-serif">Delegation 
												of powers of the Authority
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												8.<span style="font-family: Arial,sans-serif">Chief 
												executive officer </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												9.<span style="font-family: Arial,sans-serif">Staff 
												of the Authority </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												10.<span style="font-family: Arial,sans-serif">Protection 
												from personal liability </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Handling of requests for 
												approvals </span></i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												11.<span style="font-family: Arial,sans-serif">Application 
												for contained or confined use
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												12.<span style="font-family: Arial,sans-serif">Application 
												for introduction into the 
												environment </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												13.<span style="font-family: Arial,sans-serif">Application 
												to import or place on the market
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												14.<span style="font-family: Arial,sans-serif">Application 
												to export </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												15.<span style="font-family: Arial,sans-serif">Genetically 
												modified organisms in transit
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												16.<span style="font-family: Arial,sans-serif">Confidential 
												information </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												17.<span style="font-family: Arial,sans-serif">Acknowledgement 
												of application </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												18.<i><span style="font-family: Arial,sans-serif">Gazette
												</span></i>
												<span style="font-family: Arial,sans-serif">
												publication </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												19.<span style="font-family: Arial,sans-serif">Risk 
												assessment and risk management
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												20.<span style="font-family: Arial,sans-serif">Exemption
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												21.<span style="font-family: Arial,sans-serif">Determination 
												of application </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												22.<span style="font-family: Arial,sans-serif">Communication 
												of decision </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												23.<span style="font-family: Arial,sans-serif">Register
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Reviews and approvals </span>
												</i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												24.<span style="font-family: Arial,sans-serif">Review 
												of approval </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												25.<span style="font-family: Arial,sans-serif">Withholding 
												information </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												26.<span style="font-family: Arial,sans-serif">Appeals 
												Tribunal </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Technical advisory committee
												</span></i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												27.<span style="font-family: Arial,sans-serif">Technical 
												advisory committee </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												28.<span style="font-family: Arial,sans-serif">Functions 
												of the committee </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												29.<span style="font-family: Arial,sans-serif">Allowances</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												30.<span style="font-family: Arial,sans-serif">Conflict 
												of interest </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Regulatory agencies </span></i>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												31.<span style="font-family: Arial,sans-serif">Functions 
												of regulatory agencies </span>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												32.<span style="font-family: Arial,sans-serif">Unintentional 
												release into the environment
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Inspections </span></i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												33.<span style="font-family: Arial,sans-serif">Appointment 
												of inspectors &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												34.<span style="font-family: Arial,sans-serif">Functions 
												of inspectors </span></p>
												<p class="Style" style="text-align: justify">
												<i>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;Finance </span></i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												35.<span style="font-family: Arial,sans-serif">Funds 
												of the Authority </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												36.<span style="font-family: Arial,sans-serif">Investment 
												of funds </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												37.<span style="font-family: Arial,sans-serif">Financial 
												year </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												38.<span style="font-family: Arial,sans-serif">Annual 
												estimates </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												39.<span style="font-family: Arial,sans-serif">Accounts 
												and audit </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Miscellaneous </span></i></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												40.<span style="font-family: Arial,sans-serif">Regulations
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												41.<span style="font-family: Arial,sans-serif">Offences 
												and penalties </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												42.<span style="font-family: Arial,sans-serif">Public 
												awareness and participation
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												43.<span style="font-family: Arial,sans-serif">Civil 
												liability and redress </span>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												44.<span style="font-family: Arial,sans-serif">Interpretation
												</span></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 111.1pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
												SCHEDULES FIRST SCHEDULE</span></b></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 8.85pt">
												<span style="font-family: Arial,sans-serif">
												CONDUCT OF BUSINESS AND AFFAIRS 
												OF THE BOARD </span></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												SECOND SCHEDULE </span></b></p>
												<p class="Style" align="center" style="text-align: center">
												<span style="font-family: Arial,sans-serif">
												INFORMATION REQUIRED IN 
												APPLICATIONS FOR CONTAINED OR 
												CONFINED USE </span></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												THlRD SCHEDULE </span></b></p>
												<p class="Style" align="center" style="text-align: center">
												<span style="font-family: Arial,sans-serif">
												INFORMATION REQUIRED IN 
												APPLICATIONS FOR RELEASE, 
												IMPORTATION AND PLACING ON THE 
												MARKET </span></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												FOURTH SCHEDULE</span></b></p>
												<p class="Style" align="center" style="text-align: center">
												<span style="font-family: Arial,sans-serif">
												RISK ASSESSMENT</span></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												FIFTH SCHEDULE</span></b></p>
												<p class="Style" align="center" style="text-align: center">
												<span style="font-family: Arial,sans-serif">
												REGULATORY AGENCIES</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
												ACT</span></b></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 40.05pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												OF THE PARLIAMENT OF THE 
												REPUBLIC OF GHANA</span></b></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												ENTITLED</span></b></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												BIOSAFETY ACT, 2011</span></b></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												AN ACT to regulate biotechnology 
												and to provide for related 
												matters. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												DATE OF ASSENT: </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												PASSED by Parliament and 
												assented to by the President:
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Scope, objectives and 
												establishment </span></i></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Scope of the Act </span></p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												1. </span>
												<span style="font-family: Arial,sans-serif">
												(1) The requirements of this Act 
												are in addition to, and not in 
												derogation of, the requirements 
												imposed by any other enactment.
												</span></p>
												<p class="Style" style="text-align: justify">
												<span style="font-family: Arial,sans-serif">
												(2) This Act does not apply to 
												genetically modified organisms 
												that are pharmaceuticals for 
												human use, and which are the 
												subject of any other enactment.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Objectives of the Act </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												2. The objectives of the Act 
												are, </span></p>
												<p class="Style" style="text-align: justify">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												to ensure an adequate level of 
												protection in the field of safe 
												development transfer, handling 
												and use of genetically modified 
												organisms resulting from 
												biotechnology that may have an 
												adverse effect on health and the 
												environment, and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												to establish a transparent and 
												predictable process to review 
												and make decisions on 
												genetically modified organisms 
												specified in paragraph <i>(a)
												</i>and related activities.
												</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Establishment </span></b>
												<span style="font-family: Arial,sans-serif">
												of the </span><b>
												<span style="font-family: Arial,sans-serif">
												National Biosafety Authority
												</span></b></p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												3. (1) There is established by 
												this Act a body corporate to be 
												known as the National Biosafety 
												Authority. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(2) Where there is a hindrance 
												to the acquisition of property 
												by the Authority, the property 
												may be acquired for the 
												Authority under the State 
												Property and Contracts Act, 1960 
												(C.A. 6) or the State Lands Act, 
												1962 (Act 125) and the cost 
												shall be borne by the Authority.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Functions of the Authority
												</span></p>
												<p class="Style" style="margin-right: .2pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												4. </span></b>
												<span style="font-family: Arial,sans-serif">
												The functions of the Authority 
												are </span></p>
												<p class="Style" style="margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												to receive, process, respond to 
												and to make decisions on 
												applications under and in 
												conformity with this Act, </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												to establish administrative 
												mechanisms to ensure the 
												appropriate handling and storage 
												of documents and data in 
												connection with the processing 
												of applications and any other 
												matters covered by this Act,
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												to act as the national focal 
												point responsible for liaising 
												with any other agency or 
												international organisations 
												concerned with biotechnology and 
												biosafety, and </span></p>
												<p class="Style" style="margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												to promote public awareness, 
												participation and education 
												concerning the activities of the 
												Authority under this Act. </span>
												</p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												The governing body </span></b>
												</p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												5. (1) The governing body of the 
												Authority is a Board consisting 
												of <i>(a) </i>an expert in 
												biotechnology and related 
												biological sciences including 
												biosafety, as the chairperson,
												</span></p>
												<p class="Style" style="margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												the chairperson of the technical 
												advisory committee established 
												under section 27, </span></p>
												<p class="Style" style="margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative of the 
												Ministry responsible for Science 
												not below the rank of Director,
												</span></p>
												<p class="Style" style="margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative of the 
												Association of Ghana Industries,
												<i>(e) </i>one legal 
												practitioner of not less than 
												ten years standing, who has a 
												sufficient background knowledge 
												relevant to the subject matter 
												of this Act, </span></p>
												<p class="Style" style="margin-right: 16.55pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(f) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative of 
												non-governmental organisations,
												<i>(g) </i>the chief executive 
												officer of the Authority, </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(h) </span></i>
												<span style="font-family: Arial,sans-serif">
												two members from the academia 
												who are persons with a 
												sufficient background knowledge 
												relevant to the subject matter 
												of this Act at least one of whom 
												is a woman, </span></p>
												<p class="Style" style="margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(i) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative of the 
												Council for Scientific and 
												Industrial Research not below 
												the rank of a Director, </span>
												</p>
												<p class="Style" style="margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(j) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative of the 
												Ministry of Food and Agriculture 
												not below the rank of a 
												Director, </span></p>
												<p class="Style" style="margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(k) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative of the 
												Ministry of Health not below the 
												rank of a Director, and </span>
												</p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(/) one representative from the 
												Customs Division of the Ghana 
												Revenue Authority, </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(2) The members of the Board 
												shall be appointed by the 
												President in accordance with 
												article 70 of the Constitution 
												and shall hold office for three 
												years. </span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(3) A member of the Board is 
												eligible for reappointment for a 
												further term not exceeding three 
												years. </span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(4) Subsections (2) and (3) do 
												not apply to the <i>ex officio
												</i>members. (5) The names of 
												the members of the Board shall 
												be published as a notice in the
												<i>Gazette. </i></span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(6) The Board is responsible for 
												the proper and efficient 
												performance of the functions of 
												the Authority. </span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(7) The Minister responsible for 
												Science may give policy 
												directives to the Board. </span>
												</p>
												<p class="Style" style="margin-right: 129.35pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												Administration</span></i></p>
												<p class="Style" style="margin-right: 129.35pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												&nbsp;</span></i><b><span style="font-family: Arial,sans-serif">Conduct 
												of business and affairs of the 
												Board </span></b></p>
												<p class="Style" style="margin-right: .7pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												6. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) The provisions relating to 
												the conduct and regulation of 
												the business and affairs of the 
												Board are set out in the First 
												Schedule </span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(2) Except as provided in the 
												First Schedule, the Board shall 
												regulate its own procedure and 
												the procedure of any of its 
												committees. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(3) The Authority shall pay to 
												members of the Board allowances 
												approved by the Minister in 
												consultation with the Minister 
												responsible for Finance. </span>
												</p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Delegation of powers of the 
												Authority </span></b></p>
												<p class="Style" style="text-align: justify">
												<span style="font-family: Arial,sans-serif">
												7. Subject to this Act, the 
												Board may, generally or in a 
												particular case, delegate to a 
												committee of the Board or to a 
												member of the Board, or to an 
												officer, employee or agent of 
												the Authority, the performance 
												of a function of the Authority 
												under this Act. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Chief executive officer </span>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												8.<span style="font-family: Arial,sans-serif">(1) 
												There shall be a chief executive 
												officer of the Authority. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(2) The President shall appoint, 
												in accordance with article 195 
												of the Constitution, the chief 
												executive officer of the 
												Authority, on the terms and 
												conditions of service stated in 
												the instrument of appointment.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(3) The chief executive officer 
												shall hold office for a period 
												not exceeding five years and is 
												eligible for re-appointment for 
												another term only. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(4) The chief executive officer 
												is responsible, subject to the 
												direction of the Board, for the 
												day to day management of the 
												affairs of the Authority. </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Staff of the Authority </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												9. The President shall appoint 
												for the Authority, in accordance 
												with article 195 of the 
												Constitution, the officers and 
												any other staff necessary for 
												the proper performance of its 
												functions under this Act, on the 
												terms and conditions of service 
												determined by the Board. </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Protection from personal 
												liability </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												10. </span>
												<span style="font-family: Arial,sans-serif">
												A matter or thing done by a 
												member of the Board or by an 
												officer, employee or agent of 
												the Authority, shall not, if the 
												matter or thing is done bona 
												fide in the performance of a 
												function of the Authority, 
												render the member, officer, 
												employee or agent personally 
												liable to an action, a claim or 
												demand. </span></p>
												<p class="Style" style="margin-right: 110.6pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												Handling requests for approval</span></i></p>
												<p class="Style" style="margin-right: 110.6pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												&nbsp;</span></i><span style="font-family: Arial,sans-serif">Application 
												for contained or confined use
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												11. </span>
												<span style="font-family: Arial,sans-serif">
												(1) A person shall not conduct a 
												contained or confined use 
												activity involving genetically 
												modified organisms or their 
												development without the written 
												approval of the Authority.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												(2) The application shall 
												include </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												the details that are set out in 
												the Second Schedule, and </span>
												</p>
												<p class="Style" style="text-align: justify">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												any other additional information 
												that the applicant may consider 
												necessary for an assessment of 
												the potential risk and benefits 
												of the requested activity.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Application for introduction 
												into the environment </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												12. (1) A person shall not 
												introduce into the environment a 
												genetically modified organism 
												without the prior written 
												approval of the Authority.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(2) A person wishing to 
												introduce a genetically modified 
												organism into the environment 
												shall submit to the Authority an 
												application describing the 
												activity for which the approval 
												is sought. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 61.9pt">
												<span style="font-family: Arial,sans-serif">
												(3) An application under 
												subsection (2) shall include <i>
												(a) </i>the information set out 
												in the Third Schedule, </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												a risk assessment as set out in 
												the Fourth Schedule, </span></p>
												<p class="Style" style="margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												a sworn declaration that the 
												information contained in the 
												application is factually 
												correct, and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												any other additional information 
												that the applicant may consider 
												necessary for an assessment of 
												the potential risks and benefits 
												of the requested activity.
												</span></p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(4) An applicant may withdraw 
												the application at any time 
												prior to the issuance of a final 
												decision by the Authority.
												</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Application to import or place 
												on the market </span></b></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												13. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) A person shall not, without 
												the prior written approval of 
												the Authority, import or place 
												on the market a genetically 
												modified organism. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 61.9pt">
												<span style="font-family: Arial,sans-serif">
												(2) An application under 
												subsection (1) shall include <i>
												(a) </i>the information set out 
												in the Third Schedule, </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												a risk assessment as set out in 
												the Fourth Schedule, and </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												any other information that the 
												applicant may consider necessary 
												for an assessment of the 
												potential risks and benefits of 
												the requested activity. </span>
												</p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Application to export </span>
												</b></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												14. </span></b>
												<span style="font-family: Arial,sans-serif">
												A person intending to export a 
												genetically modified organism 
												shall provide the Authority with 
												a written advance informed 
												agreement or the appropriate 
												certification from the competent 
												authority of the importing 
												country. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Genetically modified organisms 
												in transit </span></b></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												15. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) A person intending to 
												transport a genetically modified 
												organism through the Republic 
												which is not destined for use in 
												the Republic </span></p>
												<p class="Style" style="margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall apply to the Authority for 
												a written approval for the 
												transportation, and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall ensure that the 
												genetically modified organism is 
												properly packaged and 
												transported in accordance with 
												the Regulations and 
												international standards. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(2) An application to transport 
												genetically modified organisms 
												through the Republic shall be in 
												the form prescribed by the 
												Regulations. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(2) A person wishing to 
												introduce a genetically modified 
												organism into the environment 
												shall submit to the Authority an 
												application describing the 
												activity for which the approval 
												is sought. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 61.9pt">
												<span style="font-family: Arial,sans-serif">
												(3) An application under 
												subsection (2) shall include <i>
												(a) </i>the information set out 
												in the Third Schedule, </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												a risk assessment as set out in 
												the Fourth Schedule, </span></p>
												<p class="Style" style="margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												a sworn declaration that the 
												information contained in the 
												application is factually 
												correct, and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												any other additional information 
												that the applicant may consider 
												necessary for an assessment of 
												the potential risks and benefits 
												of the requested activity.
												</span></p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(4) An applicant may withdraw 
												the application at any time 
												prior to the issuance of a final 
												decision by the Authority.
												</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Application to import or place 
												on the market </span></b></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												13. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) A person shall not, without 
												the prior written approval of 
												the Authority, import or place 
												on the market a genetically 
												modified organism. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 61.9pt">
												<span style="font-family: Arial,sans-serif">
												(2) An application under 
												subsection (1) shall include <i>
												(a) </i>the information set out 
												in the Third Schedule, </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												a risk assessment as set out in 
												the Fourth Schedule, and </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												any other information that the 
												applicant may consider necessary 
												for an assessment of the 
												potential risks and benefits of 
												the requested activity. </span>
												</p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Application to export </span>
												</b></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												14. </span></b>
												<span style="font-family: Arial,sans-serif">
												A person intending to export a 
												genetically modified organism 
												shall provide the Authority with 
												a written advance informed 
												agreement or the appropriate 
												certification from the competent 
												authority of the importing 
												country. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Genetically modified organisms 
												in transit </span></b></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												15. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) A person intending to 
												transport a genetically modified 
												organism through the Republic 
												which is not destined for use in 
												the Republic </span></p>
												<p class="Style" style="margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall apply to the Authority for 
												a written approval for the 
												transportation, and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall ensure that the 
												genetically modified organism is 
												properly packaged and 
												transported in accordance with 
												the Regulations and 
												international standards. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(2) An application to transport 
												genetically modified organisms 
												through the Republic shall be in 
												the form prescribed by the 
												Regulations. </span></p>
												<p class="Style" style="margin-right: 235.2pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												Confidential information 16.
												</span></b>
												<span style="font-family: Arial,sans-serif">
												(1) The Authority </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall allow an applicant to 
												designate information provided 
												to the Authority in accordance 
												with the requirements of this 
												Act and the Regulations as 
												confidential information, and 
												the applicant shall supply the 
												justification for the claims of 
												confidentiality; </span></p>
												<p class="Style" style="margin-right: 1.65pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall decide whether it accepts 
												as confidential the informa­tion 
												designated as confidential by 
												the applicant; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall inform the applicant of 
												its rejection of the claim of 
												confidentiality, providing 
												reasons on request, as well as 
												an opportunity for consultation; 
												and </span></p>
												<p class="Style" style="margin-right: 1.65pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall, where an applicant 
												withdraws an application, 
												respect the applicant's claims 
												of confidentiality. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(2) The Authority shall not use 
												confidential information for a 
												purpose not authorised under 
												this Act and shall ensure that 
												the information is protected by 
												the person involved in handling 
												applications under this Act.
												</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Acknowledgement of application
												</span></b></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												17. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) On receipt of the 
												application, the Authority
												</span></p>
												<p class="Style" style="margin-right: 1.65pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall acknowledge in writing, 
												the receipt of the application 
												within seven days of the 
												receipt, and </span></p>
												<p class="Style" style="margin-right: 1.65pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												shall screen the application for 
												completeness within sixty days.
												</span></p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(2) Where an application is not 
												complete, the Authority shall 
												request the applicant to submit 
												additional information. </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Gazette </span></i><b>
												<span style="font-family: Arial,sans-serif">
												publication </span></b></p>
												<p class="Style" style="text-align: justify; margin-right: 1.4pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												18. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) The Authority shall within 
												fourteen days publish in the <i>
												Gazette, </i>a notice concerning 
												an application for release into 
												the environment, for the general 
												information of the public.
												</span></p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(2) On request, the Authority 
												may avail to a person portions 
												of an application which do not 
												qualify as confidential 
												information. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Risk assessment and risk 
												management </span></b></p>
												<p class="Style" style="text-align: justify; margin-right: 1.4pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												19. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) Where an application is 
												screened and found to be 
												complete, the Board shall act in 
												accordance with the advice of 
												the technical advisory committee 
												in respect of the risk 
												assessment conducted as set out 
												in the Fourth Schedule. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: 2.15pt">
												<span style="font-family: Arial,sans-serif">
												(2) Risk assessment shall be 
												carried out taking into account 
												available information concerning 
												a potential exposure to the 
												genetically modified organism.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: 37.4pt">
												<span style="font-family: Arial,sans-serif">
												(3) The Board may request an 
												additional risk assessment. (4) 
												On completion of the risk 
												assessment, the Board shall
												</span></p>
												<p class="Style" style="margin-right: 2.15pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												make a report giving its 
												decision and the justification 
												on the disposition of the 
												application, and </span></p>
												<p class="Style" style="margin-right: 2.15pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												indicate the measures to be 
												taken to ensure the safe use of 
												the genetically modified 
												organism. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 2.15pt">
												<span style="font-family: Arial,sans-serif">
												(5) The Board shall liaise with 
												the appropriate regulatory 
												agency to ensure that measures 
												are in place to manage and 
												control risks identified during 
												the risk assessment process.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Exemption </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.4pt">
												<span style="font-family: Arial,sans-serif">
												20. The Board may exempt a 
												genetically modified organism 
												from certain requirements of 
												section 11, 12, or 13, where it 
												is satisfied that sufficient 
												experience or information exists 
												to conclude that the genetically 
												modified organism or activity 
												does not pose a significant risk 
												to the environment. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Determination of the application
												</span></p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												21. In reaching a final decision 
												on an application, the Board 
												shall </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												take into account </span></p>
												<p class="Style" style="margin-right: 93.8pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												information submitted by the 
												applicant, <i>(b) </i>the risk 
												assessment report, </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												relevant comments submitted by 
												the public, and </span></p>
												<p class="Style" style="text-align: justify">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												socio-economic considerations 
												arising from the impact of a 
												proposed activity and of the 
												genetically modified organisms 
												on the environment. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Communication of decision </span>
												</p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												22. (1) The Board shall 
												communicate its final decision 
												to the applicant <i>(a) </i>as 
												soon as possible, but in any 
												case not later than one hundred 
												and eighty days after the 
												receipt of the complete 
												application, or </span></p>
												<p class="Style" style="margin-right: 2.15pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												within the time that the Board 
												may in special circumstances 
												determine. </span></p>
												<p class="Style" style="margin-right: 1.4pt">
												<span style="font-family: Arial,sans-serif">
												(2) The approval shall set out 
												clearly the specific conditions 
												related to the approval. </span>
												</p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(3) The approval shall be 
												specific and limited to the 
												activity authorised as set out 
												in the decision document. </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Register </span></p>
												<p class="Style" style="margin-right: 1.2pt">
												<span style="font-family: Arial,sans-serif">
												23. The Authority shall maintain 
												a register, which shall contain 
												a copy of </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												the application, </span></p>
												<p class="Style" style="margin-right: 163.65pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												the risk assessment report, <i>
												(c) </i>the decision document,
												<i>(d) </i>the approval, and
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												any other information the Board 
												may consider necessary. </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Reviews and approvals </span>
												</i></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Review of approval </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												24. (l) The Board may review a 
												decision made under section 21 
												at any time on obtaining 
												significant new scientific 
												information indicating that the 
												genetically modified organism or 
												the approved activity may 
												adversely affect human health, 
												plant health, animal health or 
												the environment. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												(2) A regulatory agency or an 
												applicant may request the Board 
												to review the Board's decision 
												under section 21 with respect to 
												an activity conducted by the 
												applicant on the ground </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												that a change in the 
												circumstances has occurred that 
												may have a material effect on 
												the outcome of the risk 
												assessment on which the decision 
												was based; or </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												that additional scientific or 
												technical information is 
												available which may have a 
												material effect on the decision 
												including the conditions, 
												limitations or requirements 
												imposed under an approval.
												</span></p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(3) Where on a review the Board 
												is satisfied that a change is 
												warranted, the Board shall issue 
												a revised approval. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												(4) The Board shall take a 
												decision on a review within one 
												hundred and fifty days from the 
												date of notification of the 
												review and shall set out the 
												reasons for the decision. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												(5) Where the Board has 
												knowledge that an activity 
												possesses potential risk to the 
												environment, the Board shall 
												take immediate action to put the 
												necessary measures in place.
												</span></p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(6) The Board shall give special 
												consideration for review 
												requests from a regulatory 
												agency. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Withholding information </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												25. (1) A person who withholds 
												information </span></p>
												<p class="Style" style="margin-right: 1.9pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												which becomes available to the 
												applicant after the approval of 
												the application, and </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												which could change the 
												evaluation of risk posed by the
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												intended activity of the person
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												commits an offence and is liable 
												on summary conviction to a fine 
												of not less than two thousand 
												five hundred penalty units and 
												not more than five thousand 
												penalty units or to a term of 
												imprisonment of not less than 
												five years and not more than ten 
												years or to both the fine and 
												the term of imprisonment. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(2) Where an applicant has 
												information which the applicant 
												ought to have disclosed with the 
												application, but does not do so, 
												the applicant commits an offence 
												and is liable on summary 
												conviction to a fine of not less 
												than two thousand five hundred 
												penalty units and not more than 
												five thousand penalty units or 
												to a term of imprisonment of not 
												less than five years and not 
												more than ten years or to both 
												the fine and the term of 
												imprisonment. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Appeals Tribunal </span></p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												26. (1) There is hereby 
												established an Appeals Tribunal 
												consisting of <i>(a) </i>an 
												eminent biological scientist as 
												the chairperson, </span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												one legal practitioner of not 
												less than ten years standing 
												with professional qualifications 
												in biotechnology or biosafety 
												matters; and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												three other members, who have 
												qualifications in biotechnology 
												and biosafety management at 
												least one of whom is a woman.
												</span></p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(2) The members of the Appeals 
												Tribunal shall be appointed by 
												the Minister and the 
												appointments shall be published 
												in the <i>Gazette. </i></span>
												</p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(3) A member of the Board shall 
												not be appointed a member of the 
												Appeals Tribunal. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												(4) The members of the Appeals 
												Tribunal shall hold office for 
												three </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												years. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												(5) A person who is aggrieved by
												</span></p>
												<p class="Style" style="margin-right: 54.2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												a refusal to grant an approval 
												under this Act, or <i>(b) </i>
												the conditions of approval under 
												this Act, or </span></p>
												<p class="Style" style="margin-right: 1.9pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												the revocation, suspension or 
												revision of an approval under 
												this Act, or </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												a refusal to treat an 
												application as confidential
												</span></p>
												<p class="Style" style="margin-right: 1.4pt">
												<span style="font-family: Arial,sans-serif">
												may appeal, within thirty days 
												of the decision of the Board, to 
												the Appeals Tribunal in the 
												prescribed manner. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(6) A person aggrieved by a 
												decision of the Appeals Tribunal 
												may, within thirty days of the 
												decision, appeal against the 
												decision to the High Court.
												</span></p>
												<p class="Style" style="margin-right: 114.45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												Technical advisory committee
												</span></i>
												<span style="font-family: Arial,sans-serif">
												TecbmUcaladvisoryconurnnttee
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												27. </span>
												<span style="font-family: Arial,sans-serif">
												(1) In addition to any other 
												committees that the Board may 
												establish under the First 
												Schedule, there is hereby 
												established a technical advisory 
												committee consisting of not more 
												than eleven persons appointed by 
												the Board for a period not 
												exceeding three years as 
												follows: </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative each from
												</span></p>
												<p class="Style" style="margin-right: 1.4pt">
												<span style="font-family: Arial,sans-serif">
												(i) the Council for Scientific 
												and Industrial Research, and
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												(ii) the Atomic Energy 
												Commission, </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												two persons one of whom is a 
												woman, who are persons 
												knowledgeable in the fields of 
												science applicable to ecology 
												and the development and release 
												of genetically modified 
												orgamsms, </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												two persons one of whom is a 
												woman who are knowledgeable in 
												socio-economic matters and 
												genetically modified organisms, 
												and </span></p>
												<p class="Style" style="margin-right: 119.75pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												one representative each from the</span></p>
												<p class="Style" style="margin-right: 119.75pt">
												<span style="font-family: Arial,sans-serif">
												&nbsp;(i) Ghana Revenue Authority,
												</span></p>
												<p class="Style" style="margin-right: 80.85pt">
												<span style="font-family: Arial,sans-serif">
												(ii) Environmental Protection 
												Agency, </span></p>
												<p class="Style" style="margin-right: 80.85pt">
												<span style="font-family: Arial,sans-serif">
												(iii) Food and Drugs Board,
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												(iv) Veterinary Services 
												Directorate, and </span></p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(v) Plant Protection and 
												Regulatory Services Directorate.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(2) The Board in consultation 
												with the Minister responsible 
												for Science shall in appointing 
												members to the committee, 
												endeavour to achieve 
												representation from a range of 
												the sciences relevant to 
												genetically modified organisms 
												and ecology. </span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(3) The Board shall designate a 
												member of the committee as the 
												chairperson of the committee.
												</span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(4) In the absence of the 
												chairperson, the members of the 
												committee shall elect one of 
												their number to act as 
												chairperson. </span></p>
												<p class="Style" style="margin-right: 2.85pt">
												<span style="font-family: Arial,sans-serif">
												(5) The acting chairperson shall 
												perform the functions of the 
												chairperson where the 
												chairperson is unable to do so.
												</span></p>
												<p class="Style" style="margin-right: 2.85pt">
												<span style="font-family: Arial,sans-serif">
												(6) A member of the committee 
												whose period of office has 
												expired is eligible for 
												reappointment. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Functions of the committee
												</span></b></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												28. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) The technical advisory 
												committee shall </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.4pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												act as the national advisory 
												body on matters concerning or 
												related to genetic modification 
												of organisms, and carry out risk 
												assessment and audit of 
												applications at the request of 
												the Board, and </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.4pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												advise, on request or of its own 
												accord, the Minister and through 
												the Board and the Minister 
												advise the Ministries and 
												appropriate bodies, on matters 
												concerning the genetic 
												modification of organisms 
												including </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(i) aspects relating to the 
												introduction and development of 
												genetically modified organisms 
												into the environment, </span>
												</p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(ii) proposals for specific 
												activities or projects 
												concerning genetic modification 
												of organisms, </span></p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(iii) aspects concerning the 
												contained use of genetically 
												modified organisms, </span></p>
												<p class="Style" style="margin-right: 1.65pt">
												<span style="font-family: Arial,sans-serif">
												(iv) the importation and 
												exportation of genetically 
												modified organisms, and </span>
												</p>
												<p class="Style" style="margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(v) proposed Regulations and 
												written guidelines. </span></p>
												<p class="Style" style="margin-right: 1.4pt">
												<span style="font-family: Arial,sans-serif">
												(2) The committee shall annually 
												submit a budget to the Board. 
												(3) The committee may appoint 
												subcommittees to deal with 
												specific matters as required.
												</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Allowances </span></b></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												29. </span></b>
												<span style="font-family: Arial,sans-serif">
												The members of the technical 
												advisory committee and of a 
												sub­committee shall be paid the 
												allowances determined by the 
												Minister, in consultation with 
												the Minister responsible for 
												Finance. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Conflict of interest </span></b>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												30. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) A member of the technical 
												advisory committee who has an 
												interest, directly or indirectly 
												in a matter which is the subject 
												of consideration by the 
												committee shall disclose that 
												fact to the committee and the 
												nature of the interest and shall 
												not take part in the 
												consideration, discussion of or 
												vote on a question in respect of 
												that matter. </span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(2) A member who fails to comply 
												with subsection (1) ceases to be 
												a member of the committee.
												</span></p>
												<p class="Style" style="margin-right: 135.8pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												Regulatory agencies </span></i>
												<span style="font-family: Arial,sans-serif">
												Functions of regulatory agencies
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												31. (1) A regulatory agency 
												shall, where appropriate, 
												monitor an applicant's 
												activities to ensure that those 
												activities comply with the 
												requirements of this Act, the 
												Regulations and the conditions 
												imposed in connection with the 
												approval under this Act. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												(2) Where a regulatory agency 
												becomes aware of significant new 
												scientific information 
												indicating that approved 
												activities with genetically 
												modified organisms may adversely 
												affect the environment or pose 
												potential risks not previously 
												known, the regulatory agency 
												shall immediately inform the 
												Authority of the new information 
												and of the measures put in place 
												to ensure the continued safe use 
												of the genetically modified 
												organism. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Unintentional release into the 
												environment </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												32. (1) A regulatory agency with 
												knowledge of an unintentional or 
												unapproved introduction into the 
												environment of a genetically 
												modified organism that is likely 
												to have an adverse effect on the 
												environment, shall, within 
												twenty four hours of having that 
												knowledge, notify the Authority 
												of the occurrence. </span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(2) A notification under 
												subsection (1) shall include 
												adequate in­formation for the 
												Board to undertake a risk 
												assessment. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												(3) The Board, in consultation 
												with the regulatory agency, 
												shall determine whether an 
												action is necessary to minimize 
												an adverse effect on the 
												environment. </span></p>
												<p class="MsoNormal" align="center" style="text-align: center; line-height: normal">
												<i>
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												Inspections</span></i></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Appointment of inspectors </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												33. (1) Subject to subsection 
												(5) of section 19, the Board may 
												appoint a duly qualified person 
												as a biosafety inspector of the 
												Authority, for the area of 
												authority specified in the 
												letter of appointment. </span>
												</p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(2) The appointment of an 
												inspector under subsection (1) 
												shall be published in the <i>
												Gazette. </i></span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												(3) An individual or a company 
												incorporated in the Republic may 
												be appointed as an inspector.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Functions of inspectors </span>
												</p>
												<p class="Style" style="margin-right: 1.4pt">
												<span style="font-family: Arial,sans-serif">
												34. (1) A biosafety inspector 
												may, in the performance of a 
												function under this Act, at a 
												reasonable time and without a 
												warrant, </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												enter any premises, vessel or 
												property, which the inspector 
												has reason to believe it is 
												necessary to enter, in order to 
												ascertain whether the 
												requirements of this Act or of 
												the Regulations are, or an 
												approval under this Act is, 
												being complied with, and may be 
												accompanied by a person duly 
												authorised by the Authority;
												</span></p>
												<p class="Style" style="margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												take possession of the equipment 
												or material required for the 
												purpose for which the power to 
												enter is being exercised; <i>(c)
												</i>carry out the tests and 
												inspection and make the 
												recordings that are necessary in 
												the circumstances; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												direct that a part of the 
												premises, or anything in the 
												premises, shall be left 
												undisturbed for so long as it is 
												reasonably necessary for the 
												purposes of the test or 
												inspection; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												take appropriate samples of the 
												organisms, articles or 
												substances found in the 
												premises, an analysis or any 
												other thing relevant for the 
												purposes of this Act; </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(f) </span></i>
												<span style="font-family: Arial,sans-serif">
												in the case of anything found in 
												the premises which appears to 
												contain genetically modified 
												organism which has adversely 
												affected or is likely to 
												adversely affect the 
												environment, the biosafety 
												inspector may cause it to be 
												dismantled or subjected to a 
												process or test but not so as to 
												damage or destroy it, unless it 
												is necessary; or </span></p>
												<p class="Style" style="margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(g) </span></i>
												<span style="font-family: Arial,sans-serif">
												require the production of the 
												records which are required to be 
												kept under this Act. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												(2) In the performance of a 
												function under this Act, a 
												biosafety inspector shall supply 
												the appropriate identification.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												(3) An inspector who without 
												reasonable cause acts in 
												contravention of a provision of 
												subsections (1) and (2) commits 
												an offence and is liable on 
												summary conviction to a fine of 
												not less than two thousand five 
												hundred penalty units and not 
												more than five thousand penalty 
												units or to a term of 
												imprisonment of not less than 
												five years and not more that ten 
												years or to both the fine and 
												the term of imprisonment. </span>
												</p>
												<p class="MsoNormal" style="line-height: normal">
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												&nbsp;</span></p>
												<p class="MsoNormal" style="line-height: normal">
												<i>
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												Finance</span></i></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Funds of the Authority </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												35. The funds of the Authority 
												include </span></p>
												<p class="Style" style="margin-right: 2.4pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												the moneys appropriated by 
												Parliament for the purposes of 
												the Authority, </span></p>
												<p class="Style" style="margin-right: 2.4pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												the moneys that accrue to or 
												vest in the Authority in the 
												per­formance of its functions 
												under this Act, and </span></p>
												<p class="Style" style="margin-right: 2.4pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												the moneys from any other source 
												provided for, donated or lent to 
												the Authority, </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Investment of funds </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												36. The Authority may </span>
												</p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												invest any of its surplus funds 
												in securities, and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												place on deposit with a bank 
												approved by the Minister 
												responsible for Finance the 
												moneys not immediately required 
												for the purposes of the 
												Authority. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Financial year </span></p>
												<p class="Style" style="margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												37. The financial year of the 
												Authority shall be the same as 
												the financial year of the 
												Government. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Annual estimates </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												38. (1) Before the commencement 
												of each financial year, the 
												Board shall prepare the annual 
												estimates of revenue and 
												expenditure of the Authority for 
												the financial year. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.65pt">
												<span style="font-family: Arial,sans-serif">
												(2) The annual estimates shall 
												make provision for the estimated 
												expenditure of the Authority for 
												the fmancial year concerned and 
												in particular, shall provide for
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												the acquisition, maintenance, 
												repair and replacement of the 
												equipment and any other property 
												of the Authority, <i>(b) </i>the 
												payment of salaries, allowances 
												and any other charges in respect 
												of the staff of the Authority, 
												and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												the payment of pensions, 
												gratuities and any other charges 
												in respect of retirement 
												benefits which are payable out 
												of the funds of the Authority.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Accounts and audit </span></p>
												<p class="Style" style="margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												39. (1) The sums of money 
												provided in the estimates shall 
												not be increased without the 
												prior consent of the Board.
												</span></p>
												<p class="MsoNormal" style="line-height: normal">
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												&nbsp;</span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(2) The Authority shall keep 
												proper books and records of 
												account of the income, 
												expenditure, assets and 
												liabilities of the Authority in 
												the form approved by the 
												Auditor-General. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(3) Within three months from the 
												end of the financial year, the 
												Board shall submit for audit to 
												the Auditor-General the books 
												and accounts of the Authority 
												together with </span></p>
												<p class="Style" style="margin-right: 1.2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												a statement of the income and 
												expenditure of the Authority on 
												the last day of that year, and
												</span></p>
												<p class="Style" style="margin-right: 1.2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												a statement of the assets and 
												liabilities of the Authority on 
												the last day of that year.
												</span></p>
												<p class="Style" style="margin-right: 2.4pt">
												<span style="font-family: Arial,sans-serif">
												(4) The accounts of the 
												Authority shall be audited and 
												reported on in accordance with 
												article 187 of the Constitution.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(5) The activities and 
												operations of the Authority 
												shall be accessible to the 
												public unless there are reasons 
												of commercial confidentiality or 
												security, justifying exclusion.
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												Miscellaneous </span></i></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Regulations </span></b></p>
												<p class="Style" style="text-align: justify; margin-right: 2.15pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												40. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) The Authority may, with the 
												prior approval in writing of the 
												Minister, and in consultation 
												with the Ministers responsible 
												for Health and Food and 
												Agriculture and any other 
												relevant sector Minister make 
												Regulations, by legislative 
												instrument, for the better 
												performance of its functions 
												under this Act and in particular 
												for prescribing </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												anything required by this Act to 
												be prescribed; </span></p>
												<p class="Style" style="margin-right: 1.2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												the procedures for conducting 
												contained and confined use 
												activities involving genetically 
												modified organisms; </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												the procedures for </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												(i) the release of genetically 
												modified organisms into </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												the environment, </span></p>
												<p class="Style" style="text-align: justify; margin-right: 2.4pt">
												<span style="font-family: Arial,sans-serif">
												(ii) the importation of 
												genetically modified organisms, 
												(iii) the exportation of 
												genetically modified organisms, 
												(iv) genetically modified 
												organisms in transit; </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: 37.4pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												the procedures for appeals to 
												the Appeals Tribunal; <i>(e) </i>
												the forms to be used for 
												applications for approvals;
												</span></p>
												<p class="Style" style="margin-right: 1.2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(f) </span></i>
												<span style="font-family: Arial,sans-serif">
												the schedules of fees to cover 
												administrative costs of 
												processing applications and 
												notices; and </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(g) </span></i>
												<span style="font-family: Arial,sans-serif">
												the procedures for deregulation.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(2) Until Regulations are made 
												under subsection (1), the 
												Biosafety (Management of 
												Biotechnology) Regulations, 2007 
												(L.I. 1887) shall continue in 
												force as if made under this Act.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(3) Despite subsections (I) and 
												(2), the Authority may issue 
												guidelines in respect of the 
												matters referred to in 
												subsections (1) and (2). </span>
												</p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Offences and penalties </span>
												</b></p>
												<p class="Style" style="text-align: justify; margin-right: 1.2pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												41. </span></b>
												<span style="font-family: Arial,sans-serif">
												(I) </span>
												<span style="font-family: Arial,sans-serif">
												A person commits an offence and 
												is liable on conviction to a 
												fine of not less than two 
												thousand five hundred penalty 
												units and not more than five 
												thousand penalty units or to a 
												term of imprisonment of not less 
												than five years and not more 
												than ten years or to both the 
												fine and the term of 
												imprisonment if that person
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												makes contained or confined use, 
												releases into the environment, 
												places on the market, imports or 
												exports, a genetically modified 
												organism without the approval of 
												the Authority, or </span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												contravenes a condition attached 
												to an approval under this Act, 
												or </span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												fails to furnish an information 
												as required by or under this 
												Act, or </span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												uses or releases confidential 
												information for a purpose not 
												authorised by or under this Act, 
												or </span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												uses a genetically modified 
												organism for mischievous or 
												unethical purposes, or </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(f) </span></i>
												<span style="font-family: Arial,sans-serif">
												obstructs or fails to assist the 
												Authority or officers of the 
												Authority in the performance of 
												a function under this Act, or
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(g) </span></i>
												<span style="font-family: Arial,sans-serif">
												contravenes any other provision 
												of this Act. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(2) Where a body corporate is 
												convicted of an offence 
												specified in subsection (1) a 
												Director and any other officer 
												of that body corporate shall be 
												deemed to have committed the 
												offence for which the body 
												corporate is convicted. </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												(3) A person shall not be 
												convicted of an offence pursuant 
												to subsection (2) where it is 
												proved to the satisfaction of 
												the Court that, having regard to 
												the nature of the offence,
												</span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												that person did not consent to, 
												or did not conninve at, the 
												commission of the offence, or
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												that person did exercise the 
												degree of res on able diligence 
												as ought in the circumstances to 
												have been exercised to prevent 
												the commission of the offence.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(4) For the purposes of 
												subsections (2) and (3), a body 
												corporate includes a firm or 
												partnership and those 
												subsections shall be construed 
												accordingly in the case of a 
												firm or partnership. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Public awareness and 
												participation </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.2pt">
												<span style="font-family: Arial,sans-serif">
												42. (1) The Authority shall 
												promote public awareness 
												participation and education 
												concerning biosafety matters for 
												the benefit of the people of the 
												Republic through </span></p>
												<p class="Style" style="margin-right: .2pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												the publication of this Act and 
												of the Regulations in as many 
												languages as possible, and
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												public lectures, seminars and 
												workshops. </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												(2) The Authority shall publish 
												notices of final decisions 
												concerning applications made 
												under this Act in the <i>Gazette
												</i>and the electronic and print 
												media. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Civil liability and redress
												</span></p>
												<p class="Style" style="margin-right: .45pt">
												<span style="font-family: Arial,sans-serif">
												43. Liability or redress for a 
												damage that occurs as a result 
												of an activity under this Act is 
												subject to the applicable laws.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Interpretation </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												44. In this Act, unless the 
												context otherwise requires,
												</span></p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												&quot;Appeals Tribunal&quot; means the 
												Appeals Tribunal established 
												under section 26; </span></p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												&quot;applicant&quot; means a person who 
												submits an application pursuant 
												to a provision of this Act;
												</span></p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												&quot;Authority&quot; means the National 
												Biosafety Authority established 
												under section 3; </span></p>
												<p class="Style" style="text-align: justify">
												<span style="font-family: Arial,sans-serif">
												&quot;biotechnology&quot; means a 
												technological application that 
												uses biological systems, living 
												organisms or derivatives of 
												those systems and organisms to 
												make or modify products or 
												processes for a specific use;
												</span></p>
												<p class="Style" style="text-align: justify">
												<span style="font-family: Arial,sans-serif">
												&quot;biosafety&quot; is a term used to 
												describe efforts to reduce and 
												eliminate the potential risks 
												resulting from biotechnology and 
												its products; </span></p>
												<p class="Style" style="text-align: justify">
												<span style="font-family: Arial,sans-serif">
												&quot;confmed use&quot; means a field 
												trial of a genetically modified 
												organism in an open system in 
												which physical barriers are 
												employed to effectively limit 
												their impact with, and their 
												impact on, human and external 
												environment; </span></p>
												<p class="MsoNormal" style="line-height: normal">
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												&nbsp;</span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												&quot;contained use&quot; means an 
												activity undertaken within a 
												facility, an installation or any 
												other physical structure which 
												involves genetically modified 
												organisms that are controlled by 
												specific measures; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												&quot;genetically modified organism&quot; 
												includes an organism that has 
												been transformed by the 
												insertion of one or more genes, 
												or regulatory elements, or an 
												organism that has had its own 
												genes modified without the 
												insertion of any new genes and 
												their products; </span></p>
												<p class="Style" style="margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												&quot;genetically modified organisms 
												register&quot; means the register 
												maintained under section 23;
												</span></p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												&quot;Minister&quot; means the Minister 
												responsible for Science; 
												&quot;placing on the market&quot; means 
												making a genetically modified 
												organism available on a 
												commercial basis; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<span style="font-family: Arial,sans-serif">
												&quot;precautionary approach&quot; means 
												that where there are threats of 
												serious or irreversible damage, 
												lack of full scientific 
												certainty shall not be used as a 
												reason for postponing 
												cost­effective measures to 
												prevent environmental 
												degradation; </span></p>
												<p class="Style" style="margin-right: .2pt">
												<span style="font-family: Arial,sans-serif">
												&quot;Regulations&quot; means the 
												Regulations made under this Act; 
												and &quot;regulatory agency&quot; means a 
												regulatory agency specified in 
												the Fifth Schedule. </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
												SCHEDULES </span></i></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												FIRST SCHEDULE</span></b></p>
												<p class="Style" align="center" style="text-align: center">
												<b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;</span></b><i><span style="font-family: Arial,sans-serif">(Section 
												6) </span></i></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 4.8pt">
												<span style="font-family: Arial,sans-serif">
												PROVISIONS AS TO THE CONDUCT OF 
												BUSINESS AND AFFAIRS OF THE 
												BOARD </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Committees and co-opted advisers
												</span></b></p>
												<p class="Style" style="text-align: justify; margin-right: 2.15pt">
												<span style="font-family: Arial,sans-serif">
												1. (1) The Board shall establish 
												the committees it considers 
												appropriate to perform the 
												functions and e:x;ercise the 
												responsibilities determined by 
												the Board. </span></p>
												<p class="Style" style="margin-right: 2.15pt">
												<span style="font-family: Arial,sans-serif">
												(2) The findings of a committee 
												shall be presented to the Board 
												for its consideration and 
												determination. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(3) The Board may at any time 
												co-opt a person to attend any of 
												its meetings, but a co-opted 
												person is not entitled to vote 
												on a matter for decision by the 
												Board. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Vacation of office </span></b>
												</p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												2. </span></b>
												<span style="font-family: Arial,sans-serif">
												(1) The appointment of a member 
												of the Board, other than an <i>
												ex- </i></span></p>
												<p class="Style" style="text-align: justify; margin-right: 107.25pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												officio </span></i>
												<span style="font-family: Arial,sans-serif">
												member, shall be terminated by 
												the President <i>(a) </i>on the 
												expiry of the appointment, or <i>
												(b) </i>on the death of the 
												member, or </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												if the member </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (i) 
												&nbsp;&nbsp; is adjudged bankrupt, or is 
												sentenced for an offence to a 
												term of imprisonment of not less 
												than six months, or </span></p>
												<p class="Style" style="margin-right: 2.4pt">
												<span style="font-family: Arial,sans-serif">
												(ii) is convicted of an offence 
												involving fraud, dishonesty or 
												moral turpitude, or </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.4pt">
												<span style="font-family: Arial,sans-serif">
												(iii) is absent, without the 
												permission of the Board, from 
												three successive meetings of the 
												Board for which the member has 
												received notice; </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												on notice in writing of the 
												intention to resign from office; 
												or <i>(e) </i>if in the opinion 
												of the Board, the member becomes 
												by reason of mental or physical 
												infirmity, incapable of 
												performing the functions of 
												office as a member of the Board; 
												or </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(f) </span></i>
												<span style="font-family: Arial,sans-serif">
												on the commission of an offence 
												under this Act. </span></p>
												<p class="Style" style="margin-right: 3.35pt">
												<span style="font-family: Arial,sans-serif">
												(2) A member of the Board may 
												resign at any time from office 
												in writing addressed to the 
												President through the Minister.
												</span></p>
												<p class="Style" style="margin-right: 3.35pt">
												<span style="font-family: Arial,sans-serif">
												(3) The President may by letter 
												addressed to a member revoke the 
												appointment of that member.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.65pt">
												<span style="font-family: Arial,sans-serif">
												(4) Where a member of the Board 
												is, for a sufficient reason, 
												unable to act as a member, the 
												Minister shall determine whether 
												the inability would result in 
												the declaration of a vacancy.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.65pt">
												<span style="font-family: Arial,sans-serif">
												(5) Where there is vacancy, the 
												Minister shall notify the 
												President of the vacancy and the 
												President shall appoint a person 
												to fill the vacancy. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Meetings of board </span></b>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												3.<span style="font-family: Arial,sans-serif">(1) 
												The Board shall meet at least 
												four times in every financial 
												year. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.65pt">
												<span style="font-family: Arial,sans-serif">
												(2) The chairperson shall 
												preside at the meetings of the 
												Board, and in the absence of the 
												chairperson, the members present 
												shall elect one of their number 
												to preside at the meeting.
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.9pt">
												<span style="font-family: Arial,sans-serif">
												(3) Unless a unanimous decision 
												is reached, a decision on a 
												matter before the Board shall be 
												determined by a majority of the 
												votes of the members present and 
												voting, and in the case of an 
												equality of votes, the 
												chairperson or the member 
												presiding shall have a casting 
												vote. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.65pt">
												<span style="font-family: Arial,sans-serif">
												(4) The quorum for the 
												transaction of the business of 
												the Board is seven members of 
												the Board but in respect of 
												financial matters or any other 
												matter of importance as 
												determined by the Board, the 
												quorum shall be nine members.
												</span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Disclosure of interest </span>
												</b></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												4. </span></b>
												<span style="font-family: Arial,sans-serif">
												A member of the Board who has an 
												interest, directly or 
												indirectly, in an application or 
												any other matter which is the 
												subject of consideration by the 
												Board shall disclose the fact to 
												the Board and shall not take 
												part in the consideration or 
												discussion of or vote on, a 
												question in respect of the 
												application or that other 
												matter. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Seal of the board </span></b>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												5. </span></b>
												<span style="font-family: Arial,sans-serif">
												(l) The seal of the Authority 
												shall be authenticated by the 
												signatures of the chairperson of 
												the Board and the chief 
												executive officer of the 
												Authority. </span></p>
												<p class="Style" style="text-align: justify; margin-right: 1.2pt">
												<span style="font-family: Arial,sans-serif">
												(2) In the absence of the 
												chairperson, a member of the 
												Board designated by the 
												chairperson for the purpose may 
												authenticate the seal. </span>
												</p>
												<p class="Style" align="center" style="text-align: center; margin-right: 114.0pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; SECOND SCHEDULE</span></b></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 114.0pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</span></b><i><span style="font-family: Arial,sans-serif">(Section
												</span>
												<span style="font-family: Arial,sans-serif">
												11) </span></i></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 35.5pt">
												<span style="font-family: Arial,sans-serif">
												INFORMATION REQUIRED IN 
												APPLICATIONS FOR CONTAINED OR 
												CONFINED USE </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<span style="font-family: Arial,sans-serif">
												1. An application to conduct 
												activities under contained or 
												confined use with genetically 
												modified organisms under 
												contained use shall be submitted 
												to the Authority at least sixty 
												days before the activities are 
												due to begin. </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												2. The application shall include
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												the name and contact address of 
												the applicant, </span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												the location where the contained 
												use activities are to be 
												undertaken, </span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												the nature and identity of the 
												genetically modified organisms 
												to be involved, </span></p>
												<p class="Style" style="text-align: justify; margin-right: .7pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												the nature and purpose of the 
												activities including storing, 
												transporting, producing, 
												processing, disposing or use of 
												the genetically modified 
												organisms in any other way,
												</span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												a description of the potential 
												risks associated with the 
												genetically modified organism 
												activities to be undertaken, <i>
												(f) </i>a description of the 
												potential risk associated with 
												genetically modified organism 
												activities to be undertaken, and
												</span></p>
												<p class="Style" style="margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(g) </span></i>
												<span style="font-family: Arial,sans-serif">
												a description of the remedial 
												measures to be undertaken for 
												unintentional release at the end 
												of the acitivity. </span></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 118.05pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp; THIRD SCHEDULE </span></b>
												</p>
												<p class="Style" align="center" style="text-align: center; margin-right: 118.05pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(Sections </span></i>
												<span style="font-family: Arial,sans-serif">
												12, 13) </span></p>
												<p class="Style" align="center" style="text-align: center">
												<span style="font-family: Arial,sans-serif">
												INFORMATION REQUIRED IN 
												APPLICATIONS FOR RELEASE, 
												IMPORTATION AND PLACING ON THE 
												MARKET </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												1.<span style="font-family: Arial,sans-serif">N 
												arne, address and contact 
												details of the exporter. </span>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												2.<span style="font-family: Arial,sans-serif">N 
												arne, address and contact 
												details of the importer. </span>
												</p>
												<p class="Style" style="text-align: justify; text-indent: 0in; margin-left: 0in">
												3.<span style="font-family: Arial,sans-serif">Name 
												and identity of the genetically 
												modified organism as well as the 
												domestic classification of the 
												biosafety level of the 
												genetically modified organism in 
												the country of export. </span>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												4.<span style="font-family: Arial,sans-serif">Intended 
												date of the transboundary 
												movement. </span></p>
												<p class="Style" style="text-align: justify; text-indent: 0in; margin-left: 0in">
												5.<span style="font-family: Arial,sans-serif">Taxonomic 
												status, scientific and technical 
												names, common name, unique 
												identifier, transformation code 
												or event point collection or 
												acquisition and characteristics 
												of the recipient organism or 
												parental organism related to 
												biosafety. </span></p>
												<p class="Style" style="text-align: justify; text-indent: 0in; margin-left: 0in">
												6.<span style="font-family: Arial,sans-serif">Center 
												of origin and center of genetic 
												diversity, of the recipient 
												organism and the parental 
												organism and the description of 
												the habitat where the organism 
												is related to biosafety. </span>
												</p>
												<p class="Style" style="text-align: justify; text-indent: 0in; margin-left: 0in">
												7.<span style="font-family: Arial,sans-serif">Taxonomic 
												status, common name, point of 
												collection or acquisition and 
												characteristics of the 
												modification introduced, the 
												technique used and the resulting 
												characteristics of the 
												genetically modified organism.
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in; margin-right: .2pt">
												8.<span style="font-family: Arial,sans-serif">Intended 
												use of the genetically modified 
												organism and the products of the 
												genetically modified organism.
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in; margin-right: .2pt">
												9.<span style="font-family: Arial,sans-serif">Quantity 
												or volume of the genetically 
												modified organism to be 
												transferred and released. </span>
												</p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												10.<span style="font-family: Arial,sans-serif">The 
												appropriate risk assessment 
												report. </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												11.<span style="font-family: Arial,sans-serif">Suggested 
												methods for the safe handling, 
												storage, transport and use, 
												including procedures for 
												unintentional or accidental 
												release. </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												12.<span style="font-family: Arial,sans-serif">A 
												sworn declaration of the 
												applicant that the above 
												mentioned information is 
												factually correct. </span></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 109.9pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												&nbsp;</span></b></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 109.9pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												FOURTH SCHEDULE </span></b></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 109.9pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(Section </span></i>
												<span style="font-family: Arial,sans-serif">
												12, 13, 19) </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp; 
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RISK 
												ASSESSMENT </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Objective of risk assessment
												</span></b></p>
												<p class="Style" style="text-align: justify">
												<b>
												<span style="font-family: Arial,sans-serif">
												1. </span></b>
												<span style="font-family: Arial,sans-serif">
												The objective of the risk 
												assessment is to identify and 
												evaluate the potential adverse 
												effects of genetically modified 
												organisms on health and the 
												environment. </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												<b>13.<span style="font-family: Arial,sans-serif">Use 
												of risk assessment </span></b>
												</p>
												<p class="Style" style="margin-right: .2pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												2. </span></b>
												<span style="font-family: Arial,sans-serif">
												The risk assessment shall be 
												used by the Board to make 
												informed decisions regarding 
												genetically modified organism.
												</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												3. The general principles 
												guiding risk assessment are,
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												risk assessment shall be carried 
												out in a scientifically sound 
												and transparent manner and may 
												take into account expert advice 
												and guiding principles developed 
												by relevant organisations;
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												lack of scientific knowledge or 
												scientific consensus shall not 
												necessarily be interpreted to 
												indicate a particular level of 
												risk, an absence of risk or an 
												acceptable risk; and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												risk associated with genetically 
												modified organisms or products 
												of these organisms shall be 
												considered in the context of the 
												risk posed by the genetically 
												modified organism's recipient or 
												the parental organisms in the 
												likely potential receiving 
												environment. </span></p>
												<p class="Style"><b>
												<span style="font-family: Arial,sans-serif">
												Methodology </span></b></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												4. To fulfill its objective, 
												risk assessment shall entail
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) </span></i>
												<span style="font-family: Arial,sans-serif">
												an identification of any of the 
												genotypic and phenotypic 
												characteristics associated with 
												genetically modified organisms 
												that may have an adverse effect 
												on the environment; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) </span></i>
												<span style="font-family: Arial,sans-serif">
												an evaluation of the likelihood 
												of these adverse effects being 
												realised, taking into account 
												the level and the kind of 
												exposure of the likely potential 
												receiving environment of the 
												genetically modified organism;
												</span></p>
												<p class="Style" style="margin-right: 1.9pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(c) </span></i>
												<span style="font-family: Arial,sans-serif">
												an evaluation of the 
												consequences should these 
												effects be realised; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) </span></i>
												<span style="font-family: Arial,sans-serif">
												an estimation of the overall 
												risk posed by the genetically 
												modified organisms based on the 
												evaluation of the likelihood and 
												consequences of the identified 
												adverse effects being realized;
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(e) </span></i>
												<span style="font-family: Arial,sans-serif">
												a recommendation as to whether 
												or not the risks are acceptable 
												or manageable, including 
												identification of strategies to 
												mange the risk; and </span></p>
												<p class="Style" style="text-align: justify; margin-right: .95pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(f) </span></i>
												<span style="font-family: Arial,sans-serif">
												where there is uncertainty 
												regarding the level of risk, the 
												Board may request further 
												information on the specific 
												issues of concern or may 
												recommend appropriate risk 
												management strategies and 
												monitoring of the genetically 
												modified organisms in the 
												receiving environment. </span>
												</p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Points to consider </span></p>
												<p class="Style" style="margin-right: 2.15pt">
												<span style="font-family: Arial,sans-serif">
												5. Risk assessment shall take 
												into account the relevant 
												technical and scientific details 
												regarding the characteristics 
												of, </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(a) recipient organisms or 
												parental organisms: </span></i>
												<span style="font-family: Arial,sans-serif">
												the biological char­acteristics 
												of the recipient organism or 
												parental organism including 
												taxonomic status, common name, 
												origin, centers of origin and 
												centers of genetic diversity and 
												a description of the habitat 
												where the organism persists;
												</span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(b) donor organism: </span></i>
												<span style="font-family: Arial,sans-serif">
												taxonomic status and common 
												name, source and the relevant 
												biological characteristics of 
												the donor organisms; </span></p>
												<p class="Style"><i>
												<span style="font-family: Arial,sans-serif">
												(c) vector: </span></i>
												<span style="font-family: Arial,sans-serif">
												characteristics of the vector 
												including its identity of origin 
												and host range; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(d) insert and characteristics 
												of modification: </span></i>
												<span style="font-family: Arial,sans-serif">
												genetic characteristics of the 
												inserted nucleic acid and the 
												function it specifies and 
												characteristics of the 
												modification introduced; </span>
												</p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(e) genetically modified 
												organisms: </span></i>
												<span style="font-family: Arial,sans-serif">
												identity of the genetically 
												modi­fied organisms and the 
												differences between the 
												biological characteristics of 
												the genetically modified 
												organisms and those of the 
												recipient organism or parental 
												organisms; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(f) </span>
												<span style="font-family: Arial,sans-serif">
												detection and identification of 
												genetically modified organisms:
												</span></i>
												<span style="font-family: Arial,sans-serif">
												suggested detection 
												identification methods and the 
												specificity, sensitivity and 
												reliability; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(g) information relating to the 
												intended use: </span></i>
												<span style="font-family: Arial,sans-serif">
												information related to the 
												intended use of the genetically 
												modified organisms including new 
												or changed use compared to the 
												recipient organism or parental 
												organism; </span></p>
												<p class="Style" style="text-align: justify; margin-right: .45pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(h) receiving environment:
												</span></i>
												<span style="font-family: Arial,sans-serif">
												information, the location, 
												geographical climatic and 
												ecological characteristics 
												including relevant information 
												on biological diversity and 
												centers of origin of the likely 
												potential receiving environment.
												</span></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 15.8pt">
												<b>
												<span style="font-family: Arial,sans-serif">
												FIFFH SCHEDULE </span></b></p>
												<p class="Style" align="center" style="text-align: center; margin-right: 15.8pt">
												<i>
												<span style="font-family: Arial,sans-serif">
												(Section 31) </span></i></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
												REGULATORY AGENCIES </span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												&nbsp;</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												1.<span style="font-family: Arial,sans-serif">The 
												Food and Drugs Board </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												2.<span style="font-family: Arial,sans-serif">The 
												Veterinary Services Directorate
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												3.<span style="font-family: Arial,sans-serif">The 
												Plant Protection and Regulatory 
												Services Directorate </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												4.<span style="font-family: Arial,sans-serif">The 
												Environmental Protection Agency
												</span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												5.<span style="font-family: Arial,sans-serif">The 
												Customs Division of the Ghana 
												Revenue Authority </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in; margin-right: .2pt">
												6.<span style="font-family: Arial,sans-serif">District 
												Assemblies, Metropolitan 
												Assemblies, Municipal Assemblies 
												and any other local government 
												authority </span></p>
												<p class="Style" style="text-indent: 0in; margin-left: 0in">
												7.<span style="font-family: Arial,sans-serif">The 
												Standards Authority. </span></p>
												<p class="MsoNormal" style="line-height: normal">
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												&nbsp;</span></p>
												<p class="Style">
												<span style="font-family: Arial,sans-serif">
												Date of <i>Gazette </i>
												notification: </span></p>
												<p class="MsoNormal" align="center" style="text-align: center; line-height: normal">
												<span style="font-size: 12.0pt; font-family: Arial,sans-serif">
												&nbsp;</span></td>
                </tr>
              </tbody>
            </table>
          </td>
        </tr>
<tr>
  <td width="76" height="50" bgcolor="#003366">&nbsp;</td>
        </tr>
